Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Bristol-Myers Squibb patents new agents for HIV

Sep. 4, 2012

Novel candidate HIV medicines presented by Bristol-Myers Squibb

Aug. 29, 2012

FDA approves new combination pill for HIV

Aug. 28, 2012

NIH awards HIV vaccine research grants

Aug. 22, 2012

Novel candidate HIV drugs designed by GlaxoSmithKline

Aug. 16, 2012

Bionor Pharma to conduct HIV vaccine combination study

Aug. 14, 2012

CytoDyn to acquire antibody inhibiting HIV entry

Aug. 1, 2012

NIH-funded trial to test vaginal ring for HIV prevention in women

July 26, 2012

DNDi and Cipla join forces to develop combination drug for pediatric HIV

July 26, 2012

Candidate AIDS drug active against resistant HIV-1

July 26, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...